Among the patients with liposarcoma, synovial cell or spindle cell sarcoma, the CD45-/VIM+/TLE1+ phenotyping panel identified CTCs in 8/9 patients, ranging from 18 to 3,711 cells (Table 3), consistent with the prior diagnosis of metastatic disease. This evidence concerns the gene TLE1 and metastatic neoplasm.